KDR and breast carcinoma: It was reported that fucoidan inhibited binding of VEGF to its receptor (VEGFR) (Koyanagi et al., 2003) and reduced VEGF expression both in vitro and in vivo in mouse breast cancer cells (Xue et al., 2012).